There are over 300,000 units of cord blood cells preserved for client families at CBR’s state-of-the-art facility in Tucson, Arizona. The company’s research and development is focused on advancing the collection, processing, and storage methods to optimize quality and cell yield.

Additionally, CBR facilitates collection of donated research samples, made available for the nearly 200 research programs worldwide that are focused on stem cell expansion and cell-based therapies.

"We are excited about the future. Cord Blood Registry maintains a leadership position in many of our markets. And our employees are the best to be found, anywhere in the world. We look forward to continuing to build on the successes of the past as we take advantage of the opportunities of the future." - Thomas E. Moore, CEO Cord Blood Registry